Isomorphic Labs
Beni Wolf is an accomplished medical professional with extensive experience in oncology and pharmaceutical development. Currently serving as Chief Medical Officer at Isomorphic Labs since June 2025, Beni previously held the same position at Relay Therapeutics from November 2019 to June 2025, KSQ Therapeutics, Inc. from April 2019 to November 2019, and as Senior Vice President at Blueprint Medicines from March 2015 to April 2019, where three programs advanced from IND to clinical proof of concept. Beni's expertise also includes roles as Senior Medical Director at Merrimack Pharmaceuticals, Medical Director at ImmunoGen, and Amgen, as well as Associate Medical Director at Genentech. Beni's academic credentials include an MD and PhD in Medicine/Biochemistry from the University of Virginia School of Medicine and a BS in Chemistry from Union College.
This person is not in any teams
This person is not in any offices
Isomorphic Labs
7 followers
Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some of the fundamental mechanisms of life. Using computational advances, we’re working at the cutting edge in the new era of ‘digital biology’. By significantly increasing the pace of scientific research and efficacy of new medicines, we will be at the forefront of breakthroughs that will benefit millions of people.